<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0009">
 <label>9</label>
 <element-citation publication-type="journal" id="sbref0009">
  <person-group person-group-type="author">
   <name>
    <surname>Ghasemiyeh</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Borhani-Haghighi</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Karimzadeh</surname>
    <given-names>I</given-names>
   </name>
   <name>
    <surname>Mohammadi-Samani</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Vazin</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Safari</surname>
    <given-names>A</given-names>
   </name>
  </person-group>
  <article-title>Major neurologic adverse drug reactions, potential drugâ€“drug interactions and pharmacokinetic aspects of drugs used in COVID-19 patients with stroke: A narrative review</article-title>
  <source>Therapeut Clin Risk Manag</source>
  <volume>16</volume>
  <year>2020</year>
  <fpage>595</fpage>
 </element-citation>
</ref>
